We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,622

Proposed new regulations for PMNOC proceedings and CSPs
  • Bereskin & Parr LLP
  • Canada
  • August 2 2017

On July 15 2017 the government published proposed new regulations to change the procedure under the Patented Medicines (Notice of Compliance


Intellectual Property Weekly Abstracts Bulletin Week Of July 31, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • August 2 2017

This is an appeal of the Federal Court’s decision allowing Gilead’s claim to invalidate Idenix’s ‘191 Patent on the grounds of insufficient disclosure


Certificates of supplementary protection: Canada’s new sui generis patent term restoration regime
  • Gowling WLG
  • Canada
  • July 24 2017

We previously reported on Bill C-30 (the “Act to implement CETA”) which made important changes to Canada’s intellectual property landscape reflecting


Canada’s patented medicines regime: Trending upward and onward
  • Gowling WLG
  • Canada
  • August 1 2017

On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 20162017 for the Patented Medicines (Notice of


CIALIS Patent Survives Validity Challenge on Appeal
  • McCarthy Tétrault LLP
  • Canada
  • May 19 2016

Last year we wrote about a trilogy of Federal Court decisions relating to Eli Lilly’s erectile dysfunction (ED) drug CIALIS (tadalafil). While Lilly


Amendments to Canada’s patent linkage provisions relating to generic and biosimilar market approval
  • DLA Piper LLP
  • Canada
  • July 17 2017

On July 14, 2017, long-awaited amendments to Canada's patent linkage provisions (the Patented Medicines (Notice of Compliance) Regulations


International Trade Compliance Update - September 2016
  • Baker McKenzie
  • Australia, Canada, European Union, United Kingdom, USA
  • September 7 2016

On 19 August 2016, the Russian Federation notified the WTO that it intends to initiate negotiations pursuant to Paragraph 1143 of the Working Party


Supreme Court of Canada Bulletin - June 30, 2017
  • Gowling WLG
  • Canada
  • June 30 2017

On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638


April 2017 International Trade Compliance Update
  • Baker McKenzie
  • European Union, United Kingdom, USA, Canada
  • April 12 2017

The WTO announced that WTO members discussed five new or enhanced proposals to advance services negotiations at meetings of the Working Party on


Supreme Court of Canada Rules on the Promise of a Patent
  • Miller Thomson LLP
  • Canada
  • July 11 2017

On June 30, 2017, the Supreme Court of Canada issued its much awaited decision on the so-called “promise doctrine” of patent utility (AstraZeneca